Listen

News 88.9 KNPR
Classical 89.7 KCNV

member station

Cancer survivor rates are tragic stories of those who did not survive are invoked on both sides of the health care debate? Does reform promise to treat the untreated or will it threaten new and exciting technologies. Dr. Nicholas Vogelzang now directs research for U.S. Oncology - the parent company of the Comprehensive Cancer Centers of Nevada and he previously headed the Nevada Cancer Institute. Vogelzang gives us his take on how cancer treatment fits into the reform debate.

Support comes from

You won’t find a paywall here. Come as often as you like — we’re not counting. You’ve found a like-minded tribe that cherishes what a free press stands for.  If you can spend another couple of minutes making a pledge of as little as $5, you’ll feel like a superhero defending democracy for less than the cost of a month of Netflix.

More Stories

KNPR
KNPR's State of Nevada
Patients always have the right to appeal an insurer's decision to turn down their request for care at a major cancer center. But the chances an appeal will be honored can vary widely by type of cancer and an individual's case.
NPR
Shots - Health News